These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30224651)

  • 1. Mutations in RECQL are not associated with breast cancer risk in an Australian population.
    Li N; Rowley SM; Goode DL; Amarasinghe KC; McInerny S; Devereux L; ; Wong-Brown MW; Lupat R; Lee JEA; Hughes S; Thompson ER; Zethoven M; Li J; Trainer AH; Gorringe KL; Scott RJ; James PA; Campbell IG
    Nat Genet; 2018 Oct; 50(10):1346-1348. PubMed ID: 30224651
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'.
    Ahmed H; Lerner-Ellis J; Cybulski C; Metcalfe K; Lubiński J; Narod SA; Akbari MR
    Nat Genet; 2018 Oct; 50(10):1348-1349. PubMed ID: 30224648
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline RECQL mutations are associated with breast cancer susceptibility.
    Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
    Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of germline mutations in breast cancer genes: RECQL.
    Bowden AR; Tischkowitz M
    Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
    Tervasmäki A; Mantere T; Hartikainen JM; Kauppila S; Lee HM; Koivuluoma S; Grip M; Karihtala P; Jukkola-Vuorinen A; Mannermaa A; Winqvist R; Pylkäs K
    Int J Cancer; 2018 Jun; 142(11):2286-2292. PubMed ID: 29341116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
    Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
    BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
    Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
    PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RECQL: a DNA helicase in breast cancer.
    Akbari MR; Cybulski C
    Oncotarget; 2015 Sep; 6(29):26558-9. PubMed ID: 26387136
    [No Abstract]   [Full Text] [Related]  

  • 9. RECQL: a new breast cancer susceptibility gene.
    Banerjee T; Brosh RM
    Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
    Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
    Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline RECQL mutations in high risk Chinese breast cancer patients.
    Kwong A; Shin VY; Cheuk IWY; Chen J; Au CH; Ho DN; Chan TL; Ma ESK; Akbari MR; Narod SA
    Breast Cancer Res Treat; 2016 Jun; 157(2):211-215. PubMed ID: 27125668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases.
    Fu W; Ligabue A; Rogers KJ; Akey JM; Monnat RJ
    Hum Mutat; 2017 Feb; 38(2):193-203. PubMed ID: 27859906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the rs1346044 Polymorphism of the Werner Syndrome Gene RECQL2 with Increased Risk and Premature Onset of Breast Cancer.
    Zins K; Frech B; Taubenschuss E; Schneeberger C; Abraham D; Schreiber M
    Int J Mol Sci; 2015 Dec; 16(12):29643-53. PubMed ID: 26690424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women.
    Wang Z; Xu Y; Tang J; Ma H; Qin J; Lu C; Wang X; Hu Z; Wang X; Shen H
    Breast Cancer Res Treat; 2009 Nov; 118(1):169-75. PubMed ID: 19205873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
    Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
    Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility.
    Ding SL; Yu JC; Chen ST; Hsu GC; Shen CY
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):263-9. PubMed ID: 17301258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.
    Prokofyeva D; Bogdanova N; Dubrowinskaja N; Bermisheva M; Takhirova Z; Antonenkova N; Turmanov N; Datsyuk I; Gantsev S; Christiansen H; Park-Simon TW; Hillemanns P; Khusnutdinova E; Dörk T
    Breast Cancer Res Treat; 2013 Jan; 137(2):533-9. PubMed ID: 23225144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of the BLM p.Q548X (c.1642C>T) mutation in breast cancer patients from Russia is no higher than in the general population.
    Anisimenko MS; Kozyakov AE; Paul GA; Kovalenko SP
    Breast Cancer Res Treat; 2014 Dec; 148(3):689-90. PubMed ID: 25399228
    [No Abstract]   [Full Text] [Related]  

  • 19. The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia.
    Imyanitov E; Prokofyeva D; Bogdanova N; Dörk T
    Breast Cancer Res Treat; 2014 Dec; 148(3):695-6. PubMed ID: 25410042
    [No Abstract]   [Full Text] [Related]  

  • 20. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
    Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
    Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.